These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities. Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides. Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor. Girdhar K; Thakur S; Gaur P; Choubey A; Dogra S; Dehury B; Kumar S; Biswas B; Dwivedi DK; Ghosh S; Mondal P J Biol Chem; 2022 May; 298(5):101889. PubMed ID: 35378127 [TBL] [Abstract][Full Text] [Related]
15. Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands Targeting Apolipoprotein B. Watanabe A; Nakajima M; Kasuya T; Onishi R; Kitade N; Mayumi K; Ikehara T; Kugimiya A J Pharmacol Exp Ther; 2016 May; 357(2):320-30. PubMed ID: 26907624 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice. Watanabe A; Katsube T Biopharm Drug Dispos; 2021 Apr; 42(4):178-187. PubMed ID: 33724506 [TBL] [Abstract][Full Text] [Related]
17. Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects. Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Yabe D; Inagaki N J Diabetes Investig; 2020 Nov; 11(6):1448-1456. PubMed ID: 32323451 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression. Kulkarni RN; Smith DM; Ghatei MA; Jones PM; Bloom SR J Endocrinol; 1996 Dec; 151(3):341-8. PubMed ID: 8994379 [TBL] [Abstract][Full Text] [Related]
19. Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure. Liu Y; Rodriguez L; Wolfe MS Bioorg Chem; 2014 Jun; 54():7-11. PubMed ID: 24691171 [TBL] [Abstract][Full Text] [Related]